Abstract
Alzheimer's disease (AD) is a chronic brain disorder that affects the brain cells finally. The common cause of AD is dementia which reduces memory, thinking, behavior, and social skills. All these changes affect a person's ability to function. It is challenging to detect the disease in the early stages. Some of the most common diagnosing techniques are Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and Single Photon Emission Computed Tomography (SPECT). These techniques provide information regarding the external and internal regions of the brain activities for diagnosing AD. Sometimes with the above methods, it is impossible to analyze AD accurately. The retina is a significant part of the eye which provides the vision to humans. Several studies made that the retina reveals that AD patients have some variations in the retina layers in addition to brain changes. Therefore, the retina becomes a biomarker for diagnosing AD. There are different techniques available for an eye examination. Most noticeable are Fundus Imaging and Optical Coherence Tomography (OCT). This paper introduces multi-layered Deep Learning (MLDL) to diagnose AD in the early stages from retinal abnormalities. Results show that the proposed approach achieved 98.7% accuracy in detecting AD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Membrane Science and Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.